Multidisciplinary treatment (MDT) perspectives in renal cell carcinoma
Ther Adv Urol
.
2023 Jun 19:15:17562872231182216.
doi: 10.1177/17562872231182216.
eCollection 2023 Jan-Dec.
Authors
Jeanny B Aragon-Ching
1
,
Robert Uzzo
2
Affiliations
1
Clinical Program Director of Genitourinary Cancers, GU Medical Oncology, Inova Schar Cancer Institute, 8081 Innovation Park Drive, Fairfax, VA 22031, USA.
2
Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
PMID:
37359736
PMCID:
PMC10286529
DOI:
10.1177/17562872231182216
No abstract available
Keywords:
Renal cell carcinoma; active surveillance; immunotherapy; tyrosine kinase inhibitors.
Publication types
Editorial